Rahmati R, Meftah E, Hamidi H, Esfahanian F (2024) A rare association of pheochromocytoma, paraganglioma, and pituitary adenoma (3PA): A case report and literature review. Medicine 103(32):e38928. https://doi.org/10.1097/md.0000000000038928

Article  PubMed  PubMed Central  CAS  Google Scholar 

O’Toole SM, Dénes J, Robledo M, Stratakis CA, Korbonits M (2015) 15 YEARS OF PARAGANGLIOMA: the association of pituitary adenomas and phaeochromocytomas or paragangliomas. Endocr Relat Cancer 22(4):T105–T122. https://doi.org/10.1530/erc-15-0241

Article  PubMed  Google Scholar 

Xekouki P, Szarek E, Bullova P et al (2015) Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J Clin Endocrinol Metab 100(5):E710–E719. https://doi.org/10.1210/jc.2014-4297

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dénes J, Swords F, Rattenberry et al (2015) Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100(3):E531–E541. https://doi.org/10.1210/jc.2014-3399

Article  PubMed  CAS  Google Scholar 

Xekouki P, Brennand A, Whitelaw B, Pacak K, Stratakis CA (2018) The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors. Horm Metab Res 51(07):419–436. https://doi.org/10.1055/a-0661-0341

Article  PubMed  PubMed Central  CAS  Google Scholar